MyAverix Finance
SHG · Healthcare
Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076)
Biotechnology
Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $9.22B, P/E ratio is 18.24, net margin is 16.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688076
Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) — FAQ
What is Sinopep-Allsino Biopharmaceutical Co. Ltd. A's market cap?
Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) has a reported market cap of $9.22B (data as of 2026-03-29).
What is 688076's P/E ratio?
The price-to-earnings (P/E) ratio for Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) is 18.24 (data as of 2026-03-29).
Does Sinopep-Allsino Biopharmaceutical Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076). Check the MyAverix Finance app for the latest dividend data.
What sector is Sinopep-Allsino Biopharmaceutical Co. Ltd. A in?
Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688076 listed on?
688076 is listed on SHG.
What is Sinopep-Allsino Biopharmaceutical Co. Ltd. A's net margin?
Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) reports a net margin of 16.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.